Chronic obstructive pulmonary disease (COPD) is one of the leading global causes of
morbidity and mortality. A hallmark of COPD is progressive airflow obstruction primarily …

Between 3 and 7 million Americans are currently diagnosed with chronic obstructive
pulmonary disease (COPD), and the true prevalence is probably greater than 16 million (1) …

Highlights•Several phenotypes characterize chronic obstructive pulmonary disease
(COPD).•Response to pharmacological treatment in COPD is highly variable.•Guidelines …

Chronic obstructive pulmonary disease (COPD) is a devastating lung disease with a high
personal and societal burden. Exposure to toxic particles and gases, including cigarette …

Chronic obstructive pulmonary disease (COPD) is a global health problem. Being a
progressive disease characterized by inflammation and predominantly caused by tobacco …

No currently available treatments reduce the progression or suppress the inflammation of
chronic obstructive pulmonary disease (COPD). However, with a better understanding of the …

Clinical phenotyping is currently used to guide pharmacological treatment decisions in
chronic obstructive pulmonary disease (COPD), a personalized approach to care. Precision …

Chronic obstructive pulmonary disease (COPD) is a leading cause of death and disability
but has only recently been explored from a cellular and molecular perspective. In COPD …

Chronic obstructive pulmonary disease (COPD) is a common respiratory disorder with
significant morbidity and mortality. Despite its prevalence, COPD is underdiagnosed, and …

Current therapy for chronic obstructive pulmonary disease (COPD) fails to alter its relentless
progression. This remains a significant challenge and unmet need. A recent advance is the …